封面
市場調查報告書
商品編碼
1390559

生物標記技術市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年,全球生物標記技術市場規模達到354億美元。展望未來, IMARC Group預計到2028年市場規模將達到759億美元,2022-2028年複合年成長率(CAGR)為13.56%。

生物標記技術是可靠且經濟高效的檢測工具,依賴脫氧核糖核酸 (DNA) 和核糖核酸 (RNA) 等遺傳生物標記來檢測病原體。這些技術廣泛應用於不同疾病和病症的早期診斷。它們也用於藥物發現和開發過程以及神經系統疾病、心血管疾病、感染、免疫和遺傳疾病以及癌症的治療。一些常用的生物標記技術包括聚合酶鏈反應(PCR)、下一代定序(NGS)和免疫測定。

生物標記技術市場趨勢:

目前,全球患有癌症、心血管、神經和自體免疫疾病的人數大幅增加。再加上對早期有效診斷的需求不斷增加,是積極影響市場的關鍵因素之一。除此之外,老年人口的增加也促進了市場的成長。此外,許多國家的管理機構增加了用於藥物發現的研發 (R&D) 資金。再加上醫療基礎設施的大幅擴張,尤其是在發展中國家,正在推動市場成長。此外,領先的市場參與者正在引入生物標記技術的眾多進步,以提供準確的患者分層。他們也正在開發數位生物標記,幫助使用數位設備收集客觀、可量化、生理和行為資料。這些數位生物標記物也與人工智慧 (AI)、機器學習 (ML) 解決方案相結合,用於巨量資料分析和綜合決策。其他主要因素,包括人們對早期發現癌症以獲得更好治療的認知不斷提高,以及個人收入水平的飆升,預計將推動市場成長。

本報告回答的關鍵問題:

  • 迄今為止,全球生物標記技術市場表現如何,未來幾年將如何表現?
  • COVID-19 對全球生物標記技術市場有何影響?
  • 主要區域市場有哪些?
  • 根據測試類型,市場的細分是什麼?
  • 根據指示,市場的細分是什麼?
  • 基於產品的市場區隔是什麼?
  • 基於技術的市場區隔是什麼?
  • 基於應用程式的市場區隔是什麼?
  • 產業價值鏈的各個階段是什麼?
  • 該行業的關鍵促進因素和挑戰是什麼?
  • 全球生物標記技術市場的結構如何?誰是主要參與者?
  • 產業競爭程度如何?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球生物標記技術市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:按測試類型分類的市場

  • 實體切片
    • 市場走向
    • 市場預測
  • 液體活體組織切片
    • 市場走向
    • 市場預測

第 7 章:按跡象分類的市場

  • 癌症
    • 市場走向
    • 市場預測
  • 傳染性疾病
    • 市場走向
    • 市場預測
  • 自體免疫疾病
    • 市場走向
    • 市場預測
  • 心血管疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章:按產品分類的市場區隔

  • 耗材
    • 市場走向
    • 市場預測
  • 測定
    • 市場走向
    • 市場預測
  • 試劑
    • 市場走向
    • 市場預測
  • 儀器
    • 市場走向
    • 市場預測

第 9 章:依科技分類的市場

  • 聚合酶鍊式反應 (PCR)
    • 市場走向
    • 市場預測
  • 次世代定序 (NGS)
    • 市場走向
    • 市場預測
  • 免疫分析
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章:按應用分類的市場細分

  • 藥物發現
    • 市場走向
    • 市場預測
  • 臨床診斷
    • 市場走向
    • 市場預測
  • 個人化醫療
    • 市場走向
    • 市場預測

第 11 章:按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 12 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章:價值鏈分析

第 14 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章:價格分析

第16章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • LI-COR Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112023A4341

Abstract

The global biomarker technologies market size reached US$ 35.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.9 Billion by 2028, exhibiting a growth rate (CAGR) of 13.56% during 2022-2028.

Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.

Biomarker Technologies Market Trends:

There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, indication, product, technology and application.

Breakup by Test Type:

Solid Biopsy

Liquid Biopsy

Breakup by Indication:

Cancer

Infectious Diseases

Autoimmune Disorders

Cardiovascular Disorders

Others

Breakup by Product:

Consumables

Assay

Reagent

Instruments

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

Immunoassay

Others

Breakup by Application:

Drug Discovery

Clinical Diagnostics

Personalized Medicine

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report:

  • How has the global biomarker technologies market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biomarker technologies market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biomarker technologies market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomarker Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Solid Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liquid Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autoimmune Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Assay
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Reagent
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Instruments
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Polymerase Chain Reaction (PCR)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Next Generation Sequencing (NGS)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immunoassay
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Drug Discovery
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Diagnostics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Personalized Medicine
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Danaher Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 F. Hoffmann-La Roche AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Illumina Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 LI-COR Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Merck KGaA
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 QIAGEN N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Waters Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2022
  • Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2022
  • Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2022
  • Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2022
  • Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
  • Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
  • Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Biomarker Technologies Market: Competitive Structure
  • Table 9: Global: Biomarker Technologies Market: Key Players